CLINICAL TRIALS PROFILE FOR AMOXAPINE

All Clinical Trials for AMOXAPINE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000272 ↗	Early Phase II Trials for Cocaine Medication Development - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1996-08-01	The purpose of this study is to develop models for early Phase II testing of potential medications for cocaine dependence: amoxapine, risperidone and other agents. The study was a controlled pilot trial of risperidone in opiate-dependent patients on methadone maintenance. The study explored whether risperidone reduced cocaine use, cocaine craving, and cocaine subjective effects in patients on methadone maintenance who abused cocaine and whether it had an acceptable side effect profile. This
NCT00000272 ↗	Early Phase II Trials for Cocaine Medication Development - 1	Completed	New York State Psychiatric Institute	Phase 2	1996-08-01	The purpose of this study is to develop models for early Phase II testing of potential medications for cocaine dependence: amoxapine, risperidone and other agents. The study was a controlled pilot trial of risperidone in opiate-dependent patients on methadone maintenance. The study explored whether risperidone reduced cocaine use, cocaine craving, and cocaine subjective effects in patients on methadone maintenance who abused cocaine and whether it had an acceptable side effect profile. This
NCT00000272 ↗	Early Phase II Trials for Cocaine Medication Development - 1	Completed	Research Foundation for Mental Hygiene, Inc.	Phase 2	1996-08-01	The purpose of this study is to develop models for early Phase II testing of potential medications for cocaine dependence: amoxapine, risperidone and other agents. The study was a controlled pilot trial of risperidone in opiate-dependent patients on methadone maintenance. The study explored whether risperidone reduced cocaine use, cocaine craving, and cocaine subjective effects in patients on methadone maintenance who abused cocaine and whether it had an acceptable side effect profile. This
NCT00000317 ↗	Early Phase II Trials for Cocaine Medication Development - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1996-08-01	The purpose of this study is to develop models for early Phase II testing of potential medications for cocaine dependence: amoxapine, risperidone and other agents. The study was a controlled pilot trial of risperidone in opiate-dependent patients on methadone maintenance. The study explored whether risperidone reduced cocaine use, cocaine craving, and cocaine subjective effects in patients on methadone maintenance who abused cocaine and whether it had an acceptable side effect profile. This

Clinical Trial Conditions for AMOXAPINE

Condition Name

Condition Name for AMOXAPINE
Intervention	Trials
Cocaine-Related Disorders	2
Substance-Related Disorders	2
Atrial Fibrillation	1
Schizophrenia	1

Condition MeSH

Condition MeSH for AMOXAPINE
Intervention	Trials
Disease	2
Cocaine-Related Disorders	2
Substance-Related Disorders	2
Atrial Fibrillation	1

Clinical Trial Locations for AMOXAPINE

Trials by Country

Trials by Country for AMOXAPINE
Location	Trials
United States	3
Brazil	1

Trials by US State

Trials by US State for AMOXAPINE
Location	Trials
New York	2
Indiana	1

Clinical Trial Progress for AMOXAPINE

Clinical Trial Phase

Clinical Trial Phase for AMOXAPINE
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	2
Phase 1	1

Clinical Trial Status

Clinical Trial Status for AMOXAPINE
Clinical Trial Phase	Trials
Completed	4

Clinical Trial Sponsors for AMOXAPINE

Sponsor Name

Sponsor Name for AMOXAPINE
Sponsor	Trials
National Institute on Drug Abuse (NIDA)	3
New York State Psychiatric Institute	3
Research Foundation for Mental Hygiene, Inc.	2

Sponsor Type

Sponsor Type for AMOXAPINE
Sponsor	Trials
Other	7
NIH	3
Industry	1